Arsh Biotech
Arsh Biotech is a Private Indian company incorporated in 2014 and based in Delhi, India. Arsh Biotech operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Arsh Biotech - Manufacturer of diagnostic kits and testing services for plant and animal diseases. Raised funding from 1 investor.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Arsh Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Arsh Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 546734296 | Kotak Mahindra Bank Ltd(Bank) | ₹24.43 Cr | 19 Sep 2019 | Satisfied |
| 758896353 | ICICI Bank Ltd(Bank) | ₹15.51 Cr | 04 Jul 2020 | Satisfied |
| 576302332 | Axis Bank Ltd(Bank) | ₹12.67 Cr | 19 Sep 2023 | Satisfied |
| 226390084 | ICICI Bank Ltd(Bank) | ₹24.25 Cr | 12 Mar 2023 | Satisfied |
| 271686588 | Kotak Mahindra Bank Ltd(Bank) | ₹21.62 Cr | 19 Sep 2020 | Open |
Charge IDs, lenders & amounts for Arsh Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹29.82 Cr | ₹-63.41 L | ₹24.00 Cr | ₹38.05 Cr | 407 |
| FY2023-24 | ₹27.76 Cr | ₹-1.19 Cr | ₹24.24 Cr | ₹35.71 Cr | 184 |
| FY2022-23 | ₹20.52 Cr | ₹-1.13 Cr | ₹9.20 Cr | ₹26.16 Cr | 150 |
| FY2021-22 | ₹17.15 Cr | ₹-36.47 L | ₹12.73 Cr | ₹27.30 Cr | 174 |
Audited financials & ratios for Arsh Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹29.82 Cr | ₹27.76 Cr | ₹20.52 Cr | ₹17.15 Cr |
| Other income | ₹66.77 L | ₹28.73 L | ₹56.89 L | ₹15.99 L |
| Total income | ₹30.49 Cr | ₹28.04 Cr | ₹21.09 Cr | ₹17.31 Cr |
| Total expenses | ₹31.30 Cr | ₹29.57 Cr | ₹22.53 Cr | ₹17.78 Cr |
| Profit before tax | ₹-82.44 L | ₹-1.55 Cr | ₹-1.47 Cr | ₹-47.41 L |
| Profit / (Loss) after tax | ₹-63.41 L | ₹-1.19 Cr | ₹-1.13 Cr | ₹-36.47 L |
| Balance sheet | ||||
| Equity / Net worth | ₹24.00 Cr | ₹24.24 Cr | ₹9.20 Cr | ₹12.73 Cr |
| Borrowings | ₹4.27 Cr | ₹6.05 Cr | ₹5.26 Cr | ₹7.36 Cr |
| Current liabilities | ₹6.61 Cr | ₹6.86 Cr | ₹6.91 Cr | ₹4.52 Cr |
| Total liabilities | ₹14.04 Cr | ₹11.47 Cr | ₹16.96 Cr | ₹14.57 Cr |
| Current assets | ₹17.26 Cr | ₹19.68 Cr | ₹12.95 Cr | ₹10.90 Cr |
| Cash & equivalents | ₹6.23 Cr | ₹6.43 Cr | ₹4.04 Cr | ₹2.44 Cr |
| Total assets | ₹38.05 Cr | ₹35.71 Cr | ₹26.16 Cr | ₹27.30 Cr |
| Employees | 407 | 184 | 150 | 174 |
Audited financials & ratios for Arsh Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹29.82 Cr | -8.2% | +8.5% | +7.2% |
| Profit after Tax | ₹-63.41 L | +26.1% | +5.7% | +2.2% |
| Net Worth | ₹24.00 Cr | +16.4% | +21.9% | +5.8% |
| Employees | 407 | +1.5% | -4.4% | +4.1% |
Audited financials & ratios for Arsh Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹29.82 Cr | ₹-63.41 L | -2.13% | -2.12% | -2.64% | -1.67% | 0.18 | ₹7.33 L |
| FY2023-24 | ₹27.76 Cr | ₹-1.19 Cr | -4.29% | +29.30% | -4.91% | -3.33% | 0.25 | ₹15.09 L |
| FY2022-23 | ₹20.52 Cr | ₹-1.13 Cr | -5.50% | +31.19% | -12.26% | -4.31% | 0.57 | ₹13.68 L |
| FY2021-22 | ₹17.15 Cr | ₹-36.47 L | -2.13% | -0.54% | -2.87% | -1.34% | 0.58 | ₹9.86 L |
Audited financials & ratios for Arsh Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,64,13,923 | 71.61% |
| Institutional Investors | 2 | 42,66,032 | 11.57% |
| Public & Others | 32 | 62,06,904 | 16.83% |
Promoter, institutional & public holding for Arsh Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
94 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.